Fennec Pharmaceuticals (FENC) P/E Ratio
P/E Ratio as of Jun 13, 2025: -15.42
Average-15.43
Median-15.75
Minimum-16.39
Maximum-12.74
-15.42
Past Month-3.11 (25.26%)
The P/E ratio for Fennec Pharmaceuticals (FENC) is -15.42 as of Jun 13, 2025. This represents a decrease of -182.55% compared to its 12-month average P/E ratio of 18.68. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Fennec Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Fennec Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Fennec Pharmaceuticals to industry peers.
Fennec Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Fennec Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Fennec Pharmaceuticals to industry peers.
Fennec Pharmaceuticals (FENC) P/E Ratio Insights
See Fennec Pharmaceuticals’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Fennec Pharmaceuticals (FENC)
Order type
Buy in
Order amount
Est. shares
0 shares
Fennec Pharmaceuticals (FENC) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $7.93 | -15.42 |
| May 1, 2025 | $6.11 | -103.56 |
| Apr 1, 2025 | $5.53 | -93.73 |
| Mar 3, 2025 | $6.77 | -67.70 |
| Feb 3, 2025 | $6.50 | -65.00 |
| Jan 2, 2025 | $6.29 | -62.90 |
Fennec Pharmaceuticals (FENC) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -15.42 | -75.60% |
| 2024 | -63.20 | +330.22% |
| 2023 | -14.69 | +25.02% |
| 2022 | -11.75 | +78.03% |
| 2021 | -6.60 | -32.10% |
| 2020 | -9.72 | — |
FAQs About Fennec Pharmaceuticals (FENC) P/E ratio
The latest P/E ratio of Fennec Pharmaceuticals (FENC) is -15.42, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Fennec Pharmaceuticals’s last 12-month average P/E ratio is 18.68, compared to its current P/E ratio of -15.42. This reflects a decrease of -182.55%.
Fennec Pharmaceuticals’s current P/E ratio of -15.42 is lower than its last 12-month average P/E of 18.68. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Fennec Pharmaceuticals’s average P/E ratio over the last 3 years is 19.98. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Fennec Pharmaceuticals’s average P/E ratio over the last 5 years is 8.1. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.